Aromasin and Cardiac failure chronic - a phase IV clinical study of FDA data

Summary:

Cardiac failure chronic is reported as a side effect among people who take Aromasin (exemestane), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Arimidex, and have Cataract.

The phase IV clinical study analyzes which people have Cardiac failure chronic when taking Aromasin. It is created by eHealthMe based on reports of 12,620 people who have side effects when taking Aromasin from the FDA, and is updated regularly.

What is Aromasin?

Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,863 Aromasin users. Check the latest studies of Aromasin.

What is Cardiac failure chronic?

Cardiac failure chronic is found to be associated with 474 drugs and 515 conditions by eHealthMe. Check the latest studies of Cardiac failure chronic.



On Jul, 16, 2026

12,620 people reported to have side effects when taking Aromasin.
Among them, 12 people (0.1%) have Cardiac failure chronic.

Could Aromasin cause Cardiac failure chronic?

Among these 12 people:

How long have people been on Aromasin when they have Cardiac failure chronic? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Cardiac failure chronic when taking Aromasin? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Cardiac failure chronic when taking Aromasin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 75 %

What are other drugs people take besides Aromasin? *

  1. Arimidex: 9 people, 75.00%
  2. Xeloda: 1 person, 8.33%
  3. Vinorelbine Tartrate: 1 person, 8.33%
  4. Methotrexate: 1 person, 8.33%
  5. Lasix: 1 person, 8.33%
  6. Lansoprazole: 1 person, 8.33%
  7. Herceptin: 1 person, 8.33%
  8. Fluorouracil: 1 person, 8.33%
  9. Femara: 1 person, 8.33%
  10. Blopress: 1 person, 8.33%

What are other side effects people have besides Cardiac failure chronic? *

  1. Dyspnea Exertional: 9 people, 75.00%
  2. Pulmonary Function Test Decreased: 9 people, 75.00%
  3. Pain: 9 people, 75.00%
  4. Mobility Decreased (ability to move is reduced): 9 people, 75.00%
  5. Impaired Work Ability: 9 people, 75.00%
  6. Quality Of Life Decreased: 9 people, 75.00%
  7. Cardiac Function Test Abnormal: 2 people, 16.67%
  8. Weight Increased: 1 person, 8.33%
  9. Blood Lactate Dehydrogenase Increased: 1 person, 8.33%
  10. Cardiac Disorder: 1 person, 8.33%

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 1 person, 8.33%
  2. Cataract (clouding of the lens inside the eye): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aromasin and have Cardiac failure chronic?

- Check whether Cardiac failure chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aromasin:

Cardiac failure chronic treatments and more:

How severe was Cardiac failure chronic and when was it recovered:

Expand to all the drugs that have ingredients of exemestane:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aromasin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure chronic:

Browse all the conditions that are associated with Cardiac failure chronic:


How the study uses the data?

The study uses data from the FDA. It is based on exemestane (the active ingredients of Aromasin) and Aromasin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: